Table 3. Hospitalization.*.
| Key Secondary Outcome | LY-CoV555 | Placebo | Incidence |
|---|---|---|---|
| no. of patients/total no. | % | ||
| Hospitalization | 9/143 | 6.3 | |
| 700 mg, 1/101 | 1.0 | ||
| 2800 mg, 2/107 | 1.9 | ||
| 7000 mg, 2/101 | 2.0 | ||
| Pooled doses, 5/309 | 1.6 | ||
Data for patients who presented to the emergency department are included in this category.